Article contents
Delayed Onset of Neuropsychiatric Effects Associated with Montelukast
Published online by Cambridge University Press: 13 June 2014
Abstract
Montelukast (a leukotriene receptor antagonist) is a commonly prescribed medication used in the management of asthma in both children and adults. It has been associated with a possible increased risk of various neuropsychiatric events in post-marketing analyses of clinical trial data and surveillance studies. When establishing a link between a medication and side effects, it is usual to establish and enquire whether there is a chronological relationship between the commencement of the medication and the onset of the symptoms.
We report a case where a number of unusual neuropsychiatric events were reported several years after commencement of montelukast in a young boy who may have a genetic predisposition and a likely psychological trigger. There was complete resolution of these symptoms upon the withdrawal of montelukast.
Keywords
- Type
- Case Report
- Information
- Copyright
- Copyright © Cambridge University Press 2012
References
- 8
- Cited by